Women’s health drugmaker Meditrina seeks fresh funding
Meditrina, which is based in Ann Arbor, Michigan, is using patents from AstraZeneca to treat women's health issues including endometriosis and uterine fibroids, which are abnormal growths or tumors that can cause pain and infertility. The company has completed Phase II trials on its two drugs - MPI-676 and MPI-674 - which treat endometriosis and abnormal uterine bleeding, respectively.